The name of the game for SyVento Biotech is improving access to advanced therapies for patients throughout Europe. Dominik Lipka, Chief Technology Officer, SyVento Biotech, is keen to further pursue possibilities with mRNA therapies with the help of Cytiva's innovative FlexFactory™ platform.
